Biolife Solutions Inc (NASDAQ: BLFS) is 63.08% higher on its value in year-to-date trading and has touched a low of $14.50 and a high of $28.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BLFS stock was last observed hovering at around $26.38 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $26.50, the stock is -0.26% and 6.00% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.11 million and changing 0.45% at the moment leaves the stock 19.02% off its SMA200. BLFS registered 65.32% gain for a year compared to 6-month gain of 23.31%. The firm has a 50-day simple moving average (SMA 50) of $24.9396 and a 200-day simple moving average (SMA200) of $22.21805.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.88% loss in the last 1 month and extending the period to 3 months gives it a 10.51%, and is -1.38% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.10% over the week and 5.57% over the month.
Biolife Solutions Inc (BLFS) has around 414 employees, a market worth around $1.23B and $123.36M in sales. Profit margin for the company is -30.10%. Distance from 52-week low is 82.76% and -8.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.63%).
The EPS is expected to grow by 66.45% this year.
Biolife Solutions Inc (BLFS) Top Institutional Holders
280.0 institutions hold shares in Biolife Solutions Inc (BLFS), with institutional investors hold 101.67% of the company’s shares. The shares outstanding are 46.23M, and float is at 45.23M with Short Float at 6.93%. Institutions hold 99.74% of the Float.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 8.71 million shares valued at $186.59 million. The investor’s holdings represent 19.1651% of the BLFS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.49 million shares valued at $117.61 million to account for 12.0797 of the shares outstanding. The other top investors are INVESCO LTD. which holds 3.32 million shares representing 7.3078% and valued at over $71.15 million, while VANGUARD GROUP INC holds 6.1332 of the shares totaling 2.79 million with a market value of $59.71 million.
Biolife Solutions Inc (BLFS) Insider Activity
The most recent transaction is an insider sale by Mathew Aby J., the company’s EVP & Chief Scientific Officer. SEC filings show that Mathew Aby J. sold 13,196 shares of the company’s common stock on Dec 17 ’24 at a price of $27.16 per share for a total of $0.36 million. Following the sale, the insider now owns 0.26 million shares.
Biolife Solutions Inc disclosed in a document filed with the SEC on Dec 16 ’24 that Mathew Aby J. (EVP & Chief Scientific Officer) sold a total of 7,604 shares of the company’s common stock. The trade occurred on Dec 16 ’24 and was made at $27.33 per share for $0.21 million. Following the transaction, the insider now directly holds 0.28 million shares of the BLFS stock.
Still, SEC filings show that on Nov 26 ’24, Wichterman Troy (Chief Financial Officer) disposed off 581 shares at an average price of $27.20 for $15803.0. The insider now directly holds 122,766 shares of Biolife Solutions Inc (BLFS).
